Helios Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,000
Closed -$1.56M 37
2025
Q2
$1.56M Hold
2,000
1.2% 22
2025
Q1
$1.65M Hold
2,000
2.89% 6
2024
Q4
$1.54M Hold
2,000
0.9% 22
2024
Q3
$1.77M Hold
2,000
1.09% 22
2024
Q2
$1.81M Hold
2,000
1.18% 23
2024
Q1
$1.56M Hold
2,000
1.09% 24
2023
Q4
$1.17M Buy
+2,000
New +$1.17M 0.92% 27

Other funds holding LLY

Helios Capital Management's LLY Position: Q3 2025 in Review

Helios Capital Management sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 2,000 shares — an estimated $1.56M sold.

Helios Capital Management first reported a position in LLY in Q4 2023 and held it in 7 quarters. The position peaked at $1.81M in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Helios Capital Management reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Helios Capital Management sold 2,000 Eli Lilly shares in Q3 2025, an estimated $1.56M.
  • Helios Capital Management first reported a position in Eli Lilly in Q4 2023 and held it in 7 quarters.
  • Helios Capital Management's Eli Lilly position peaked at $1.81M in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Helios Capital Management's 13F filing for Q3 2025, filed 27 Oct 2025.